TABLE 5.
Compoundb | No. of atomic clashes |
||
---|---|---|---|
Norfloxacin | Ethidium bromide | MBX3132 | |
CPZEC | 4 | 11 | 14 |
AMIEC | 3 | 0 | 3 |
CPZST | 6 | 3 | 15c |
AMIST | 5 | 4 | Nonec |
The calculation was performed on the representative structure of the most populated cluster extracted from each MD trajectory (in the case of amitriptyline and chlorpromazine, we selected the trajectories associated with the more negative binding free energies among those displaying a stable position of the ligand in the last 50 ns of the production run). In addition, we used the crystal structure of E. coli AcrB in which the inhibitor MBX3132 has been cocrystallized (PDB ID 5ENQ). To evaluate the number of clashes, these structures were superimposed, and the number of heavy atoms of amitriptyline/chlorpromazine that overlap the other compounds was recorded.
CPZ, chlorpromazine; AMI, amitriptyline.
Under the hypothesis that MBX3132 binds to AcrBST similarly to the mode found in the X-ray structure 5ENQ of AcrBEC.